ALX Oncology Holdings Inc. Common Stock - relatórios financeiros trimestrais (NASDAQ:ALXO) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Market Capitalization 219.79 M
Employee 43
Founded 2015
CEO N/A
Website www.alxoncology.com
Headquarter Delaware, United States
FIGI BBG00VR8SDG8
Industry Biotecnologia

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

219.79 M Capitalização de mercado

Notícias

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

ALX Oncology nomeia Jeff Knight como diretor de desenvolvimento

Wells Fargo inicia cobertura de ALX Oncology com classificação acima do peso

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

IBRX Stock Jumps on Progress in NK Cell Therapy Production

JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study

RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study

RLMD Stock Surges 42% in a Week: Here's What You Should Know

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study